RevFund 1

📉 Ignore the headlines about massive AI deals—Q1 2025 was a tough quarter for most startups.⁠
⁠
Carta’s latest report shows that while early-stage valuations are up, deal counts have dropped significantly:⁠
⁠
Seed rounds down 28% year-over-year⁠
⁠
Series A rounds down 10%⁠
⁠
Time between rounds is at record highs⁠
⁠
Nearly 1 in 5 rounds were down rounds⁠

Despite these challenges, M&A activity hit an all-time high, with 180 transactions involving Carta companies.⁠
⁠
Founders are navigating a market where capital is available but harder to secure. Staying informed is crucial.⁠
⁠
📊 Read the full report here: https://carta.com/data/state-of-private-markets-q1-2025/?utm_medium=email&utm_source=blast&utm_campaign=20250515-amer-general-data_newsletter&utm_content=&mkt_tok=MjE0LUJURC0xMDMAAAGadBOJRemAAhcN78FAz0U6eAbV2xFN4gf2DPFZPCb62G1BN_YMjcRNv-8D67atDasviurtXv_cGgXUeyN3IODp9mqWYkMpqORtztOXIUKAvov1

🚀 We’re thrilled to see our portfolio company TadHealth announce their $5.5M Series A to expand mental health services in K-12 schools.

Born from a personal mission, TadHealth is transforming how students access care—making support more scalable, data-driven, and reimbursable.

This new round, led by top healthcare executives and backed by leaders like Dr. James Hudziak, will accelerate TadHealth’s vision for proactive, tech-enabled mental health in schools nationwide.

👏 Congrats to Ben Greiner and the TadHealth team—we’re proud to have supported you from the beginning.